Evidence map›Paper›PMID 27012547›Full record

ArticleEpilepsia2016

Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain.

Suhasini Kaushal, Zenab Tamer, Freda Opoku, Patrick A Forcelli

Open access · bronzeAbstract read
In one paragraph

Article in Epilepsia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Reducing the percentage of surviving infants with acute symptomatic seizures discharged on anti-seizure medication.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Efficacy of Levetiracetam vs Phenobarbital as First Line Therapy for the Treatment of Neonatal Seizures.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Quantifying Sharpness and Nonlinearity in Neonatal Seizure Dynamics.Cyborg and bionic systems (Washington, D.C.) · 2024
    Article
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Suhasini KaushalDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, DC, U.S.A.
Zenab TamerDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, DC, U.S.A.
Freda OpokuDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, DC, U.S.A.
Patrick A ForcelliDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, DC, U.S.A.
Georgetown University · US

Funding

Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
Postdoctoral Training in Developmental Disabilities ResearchT32HD046388 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2006 to 2016
$1.5M
NCATS NIH HHS KL2 TR001432NICHD NIH HHS T32 HD046388
6 · The paper itself

Abstract

objectiveDuring critical periods of brain development, both seizures and anticonvulsant medications can affect neurodevelopmental outcomes. In rodent models, many anticonvulsants trigger neuronal apoptosis. However, white matter apoptosis (WMA) has not been examined after anticonvulsant drug treatment. Herein, we sought to determine if anticonvulsant drugs induced apoptosis in the developing white matter (WM) in a rodent model.

methodsPostnatal day (P)7 rats were treated with phenobarbital (PB-75), MK-801 (dizocilpine, 0.5), lamotrigine (LTG-20), carbamazepine (CBZ-100), phenytoin (PHT-50), levetiracetam (LEV-250), or saline; all doses are mg/kg. Brain tissue collected 24 h after treatment was stained using the terminal deoxynucleotidyl transferase dUTP nick end labeling method. The number of degenerating cells within WM, that is, anterior commissure (AC), corpus callosum, cingulum, and hippocampus-associated WM tracts, was quantified.

resultsSaline-treated rats showed low baseline level of apoptosis in developing WM on P8 in all the areas examined. PB, PHT, and MK-801 significantly increased apoptosis in all four brain areas examined. Exposure to CBZ, LTG, or LEV failed to increase apoptosis in all regions. SIGNIFICANCE: Commonly used anticonvulsants (PB, PHT) cause apoptosis in the developing WM in a rat model; the N-methyl-d-aspartate (NMDA) receptor antagonist MK-801 has a similar effect. These results are consistent with reports of anesthesia-induced WMA during brain development. Consistent with the lack of neuronal apoptosis caused by LTG, LEV, and CBZ, these drugs did not cause WMA. Many infants treated with anticonvulsant drugs have underlying neurologic injury, including WM damage (e.g., following intraventricular hemorrhage [IVH] or hypoxic-ischemic encephalopathy [HIE]). The degree to which anticonvulsant drug treatment will alter outcomes in the presence of underlying injury remains to be examined, but avoiding drugs (when possible) that induce WMA may be beneficial.

Indexed as

BrainAge FactorsAnalysis of VarianceAnimalsAnimals, NewbornAnticonvulsantsApoptosisConvulsantsDisease Models, AnimalEpilepsyFemaleIn Situ Nick-End LabelingMaleRatsWhite MatterAnticonvulsantsConvulsantsAnticonvulsantAntiepileptic drugApoptosisCell deathNeonatal

Identifiers

PMID27012547
PMCPMC5214662
OpenAlexW2304053325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.